教授，医学博士，研究生导师。毕业于中国协和医科大学，在中国医学科学院肿瘤医院工作多年，2016加盟北京大学临床肿瘤学院胸部肿瘤内科，担任科主任。主要工作为胸部肿瘤的内科治疗。 专长肺癌规范化、个体化多学科综合治疗，对于老年肺癌诊治有较深刻的认识。还专注于肺癌相关临床新药临床试验，特别是转化性临床研究。
民政部老年肿瘤专业委员会执行副总干事，及肺癌专业委员会副主任委员，非小细胞肺癌NCCN治疗指南中文版专家组秘书、全国卫生专业技术资格考试专家委员会委员。
曾主编、副主编及参与多部书籍，《应对肺癌专家谈(国家癌症中心肿瘤专家答疑丛书)》、《马丁代尔药物大典》、《临床用药须知》、《简明临床肿瘤学》、《临床肿瘤学高级教程》等多部专著。在Oncotarget. Lung Cancer. Thoracic Cancer. Cancer medicine等国际及国内核心刊物发表论文发表多篇文章，还积极参与科普宣传活动。
发表论文：
1、Hongyan Sun, Xiaoteng Sun, Xiaoyu Zhai, Jingfeng Guo, Yutao Liu, Jianming Ying
ZipingWang. Body mass index and exon 19 mutation as factors predicting the therapeutic efficacy of gefitinib in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer. Thoracic Cancer 7 (2016) 61–65
2、Ling Shan, ZipingWang, Lei Guo, Hongyan Sun, Tian Qiu, Yun Ling, Wenbin Li, Lin Li, Xiuyun Liu, Bo Zheng, Ning Lu, Jianming Ying. Concurrence of EGFR amplification and sensitizing mutations indicate a better survival benefit from EGFR-TKI therapy in lung adenocarcinoma patients. Lung Cancer 89 (2015) 337–342
3、Yixiang Zhu, Xiaoyu Zhai1, Sipeng Chen & ZipingWang. Exploration of optimal time for initiating adjuvant chemotherapy after surgical resection: A retrospective study in Chinese patients with stage IIIA non-small cell lung cancer in a single center. Thoracic Cancer 7 (2016) 399–405
4、Chunlei Ge, Shikai Wu, Weiwei Wang, Zhimin Liu, Jianhua Zhang, Zhenyu Wang, Ruilei Li, Zhiwei Zhang, Zhen Li, Suwei Dong, Ying Wang, Yuanbo Xue, Jinyan Yang, Qinghua Tan, Ziping Wang and Xin Song. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway. Oncotarget ,March 30, 2015
5、Xiaoyu Zhai, Lu Yang, Sipeng Chen, Qiwen Zheng Ziping Wang. Impact of age on adjuvant chemotherapy after radical resection in patients with non–small cell lung cancer. Cancer Medicine,31 May 2016